Ironwood Pharmaceuticals (IRWD) Debt/Equity Ratio: History & Chart

Ironwood Pharmaceuticals, Inc.(IRWD)

Drug Manufacturers - Specialty & Generic · Boston, MA

$3.65-0.00 (-0.14%)

Delayed quote: Oct 6, 2026, 1:40 PM EDT

About Ironwood Pharmaceuticals, Inc.

Ironwood Pharmaceuticals, Inc. operates as a healthcare enterprise primarily dedicated to discovering, developing, and commercializing therapeutic solutions for gastrointestinal (GI) conditions. Its flagship commercial product is linaclotide, a guanylate cyclase type-C (GC-C) agonist. This medication is prescribed for adult patients managing irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC), sold as LINZESS in the United States and Mexico, and under the CONSTELLA brand throughout Canada and the European Union. Beyond its marketed offerings, Ironwood's development pipeline includes IW-3300, another GC-C agonist targeting various visceral pain conditions, such as interstitial cystitis/bladder pain syndrome and endometriosis. Additionally, the company is advancing CNP-104, an immune nanoparticle being investigated for biliary cholangitis. Ironwood maintains key strategic alliances with AbbVie Inc., AstraZeneca AB, and Astellas Pharma Inc. to support the ongoing development and market introduction of linaclotide. Established in 1998, the Boston, Massachusetts-based firm initially operated as Microbia, Inc. before officially rebranding to Ironwood Pharmaceuticals, Inc. in April 2008.

Boston, MA

100 employees

www.ironwoodpharma.com

Healthcare / Drug Manufacturers - Specialty & Generic

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
CEO: Thomas A. McCourt

View full financials

IRWD Debt to Equity Ratio Metrics

DEBT TO EQUITY RATIO

-2.45

DEBT TO EQUITY RATIO AVG TTM

-2.34

DEBT TO EQUITY RATIO AVG 3Y

-2.12

DEBT TO EQUITY RATIO AVG 5Y

-1.05

DEBT TO EQUITY RATIO AVG 10Y

-0.95

DEBT TO EQUITY RATIO AVG 15Y

0.34

DEBT TO EQUITY RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

-4.85%

CURRENT VS 3Y AVG

-15.41%

CURRENT VS 5Y AVG

-134.10%

CURRENT VS 10Y AVG

-156.96%

CURRENT VS 15Y AVG

-811.55%

CURRENT VS 20Y AVG

N/A

SECTOR MEDIAN · HEALTHCARE

0.11

median of 740 covered companies

CURRENT VS SECTOR MEDIAN

-2329.24%

vs the sector median at left

NAME	MARKET CAP	DEBT TO EQUITY RATIO	TTM	3Y	5Y
Ironwood Pharmaceuticals, Inc. (IRWD)	$600.01M	-2.45	-2.34	-2.12	-1.05
AngioDynamics, Inc. (ANGO)vs ›	$590.43M	0.00	0.03	0.06	0.06
OrthoPediatrics Corp. (KIDS)vs ›	$586.18M	0.27	0.26	0.14	0.13
Fulgent Genetics, Inc. (FLGT)vs ›	$585.92M	0.01	0.01	0.02	0.02
Climb Bio, Inc. (CLYM)vs ›	$616.60M	0.01	0.00	0.00	0.00
Prime Medicine, Inc. (PRME)vs ›	$628.55M	2.83	0.61	0.35	0.24
Aquestive Therapeutics, Inc. (AQST)vs ›	$571.50M	N/A	4.68	4.68	4.68
Aura Biosciences, Inc. (AURA)vs ›	$633.55M	0.05	0.13	0.11	0.08
SOPHiA GENETICS S.A. (SOPH)vs ›	$633.41M	0.74	0.83	0.46	0.33
CorMedix Inc. (CRMD)vs ›	$564.85M	0.31	0.19	0.10	0.07

NAME

MARKET CAP

DEBT TO EQUITY RATIO

TTM

Ironwood Pharmaceuticals, Inc. (IRWD)

$600.01M

-2.45

-2.34

-2.12

-1.05

AngioDynamics, Inc. (ANGO)vs ›

$590.43M

0.00

0.03

0.06

OrthoPediatrics Corp. (KIDS)vs ›

$586.18M

0.27

0.26

0.14

0.13

Fulgent Genetics, Inc. (FLGT)vs ›

$585.92M

0.01

0.02

Climb Bio, Inc. (CLYM)vs ›

$616.60M

0.01

0.00

Prime Medicine, Inc. (PRME)vs ›

$628.55M

2.83

0.61

0.35

0.24

Aquestive Therapeutics, Inc. (AQST)vs ›

$571.50M

N/A

4.68

Aura Biosciences, Inc. (AURA)vs ›

$633.55M

0.05

0.13

0.11

0.08

SOPHiA GENETICS S.A. (SOPH)vs ›

$633.41M

0.74

0.83

0.46

0.33

CorMedix Inc. (CRMD)vs ›

$564.85M

0.31

0.19

0.10

0.07

Debt to Equity Ratio FAQ

What is the debt to equity ratio for Ironwood Pharmaceuticals, Inc. (IRWD)?

The debt to equity ratio for IRWD stock is -2.45.

Is Ironwood Pharmaceuticals, Inc.'s debt to equity ratio high or low?

The debt to equity ratio of -2.45 is 134% below its 5-year average of -1.05, near the low end of its 5-year range (-2.75–1.04).

What is the TTM average debt to equity ratio for Ironwood Pharmaceuticals, Inc. (IRWD)?

The TTM average debt to equity ratio for IRWD stock is -2.34.

What is the 3Y average debt to equity ratio for Ironwood Pharmaceuticals, Inc. (IRWD)?

The 3Y average debt to equity ratio for IRWD stock is -2.12.

What is the 5Y average debt to equity ratio for Ironwood Pharmaceuticals, Inc. (IRWD)?

The 5Y average debt to equity ratio for IRWD stock is -1.05.

What is the 10Y average debt to equity ratio for Ironwood Pharmaceuticals, Inc. (IRWD)?

The 10Y average debt to equity ratio for IRWD stock is -0.95.

What is the 15Y average debt to equity ratio for Ironwood Pharmaceuticals, Inc. (IRWD)?

The 15Y average debt to equity ratio for IRWD stock is 0.34.

DATE	DEBT TO EQUITY RATIO
2026-06-30	-2.45
2026-03-31	-2.75
2025-12-31	-2.28
2025-09-30	-2.26
2025-06-30	-1.94
2025-03-31	-1.79
2024-12-31	-1.99
2024-09-30	-1.97
2024-06-30	-1.99
2024-03-31	-2.09
2023-12-31	-2.07
2023-09-30	-2.29
2023-06-30	-2.36
2023-03-31	0.59
2022-12-31	0.64
2022-09-30	0.70
2022-06-30	0.78
2022-03-31	1.04
2021-12-31	0.79
2021-09-30	0.81
2021-06-30	0.91
2021-03-31	4.17
2020-12-31	7.24
2020-09-30	75.95
2020-06-30	-12.01
2020-03-31	-6.11
2019-12-31	-4.62
2019-09-30	-2.99
2019-06-30	-1.97
2019-03-31	-2.10
2018-12-31	-2.11
2018-09-30	-2.07
2018-06-30	-9.26
2018-03-31	-22.36
2017-12-31	40.63
2017-09-30	-22.55
2017-06-30	80.69
2017-03-31	13.14
2016-12-31	5.59
2016-09-30	6.36
2016-06-30	4.63
2016-03-31	4.17
2015-12-31	4.01
2015-09-30	3.81
2015-06-30	2.73
2015-03-31	2.56
2014-12-31	2.00
2014-09-30	1.65
2014-06-30	1.26
2014-03-31	0.95
2013-12-31	4.68
2013-09-30	2.13
2013-06-30	1.26
2013-03-31	2.99
2012-12-31	0.00
2012-09-30	0.00
2012-06-30	0.00
2012-03-31	0.00
2011-12-31	0.01
2011-09-30	0.01
2011-06-30	0.01
2011-03-31	0.01
2010-12-31	0.00
2010-09-30	0.00
2010-06-30	0.02
2010-03-31	0.02
2009-12-31	-0.01
2009-09-30	0.19
2009-06-30	0.00
2009-03-31	0.00
2008-12-31	-0.01

DATE

DEBT TO EQUITY RATIO

2026-06-30

-2.45

2026-03-31

-2.75

2025-12-31

-2.28

2025-09-30

-2.26

2025-06-30

-1.94

2025-03-31

-1.79

2024-12-31

-1.99

2024-09-30

-1.97

2024-06-30

-1.99

2024-03-31

-2.09

2023-12-31

-2.07

2023-09-30

-2.29

2023-06-30

-2.36

2023-03-31

0.59

2022-12-31

0.64

2022-09-30

0.70

2022-06-30

0.78

2022-03-31

1.04

2021-12-31

0.79

2021-09-30

0.81

2021-06-30

0.91

2021-03-31

4.17

2020-12-31

7.24

2020-09-30

75.95

2020-06-30

-12.01

2020-03-31

-6.11

2019-12-31

-4.62

2019-09-30

-2.99

2019-06-30

-1.97

2019-03-31

-2.10

2018-12-31

-2.11

2018-09-30

-2.07

2018-06-30

-9.26

2018-03-31

-22.36

2017-12-31

40.63

2017-09-30

-22.55

2017-06-30

80.69

2017-03-31

13.14

2016-12-31

5.59

2016-09-30

6.36

2016-06-30

4.63

2016-03-31

4.17

2015-12-31

4.01

2015-09-30

3.81

2015-06-30

2.73

2015-03-31

2.56

2014-12-31

2.00

2014-09-30

1.65

2014-06-30

1.26

2014-03-31

0.95

2013-12-31

4.68

2013-09-30

2.13

2013-06-30

1.26

2013-03-31

2.99

2012-12-31

0.00

2012-09-30

0.00

2012-06-30

0.00

2012-03-31

0.00

2011-12-31

0.01

2011-09-30

0.01

2011-06-30

0.01

2011-03-31

0.01

2010-12-31

0.00

2010-09-30

0.00

2010-06-30

0.02

2010-03-31

0.02

2009-12-31

-0.01

2009-09-30

0.19

2009-06-30

0.00

2009-03-31

0.00

2008-12-31

-0.01

Debt to Equity Ratio: -2.45

IRWD Debt to Equity Ratio

IRWD Average Debt to Equity Ratio Chart

IRWD Current vs Average Debt to Equity Ratio Chart

IRWD Debt to Equity Ratio Metrics

IRWD Competitors' Debt to Equity Ratio

Financial Health

Debt to Equity Ratio Formula & Definition

Debt to Equity Ratio FAQ

IRWD Debt to Equity Ratio History

Related Metrics